Press Releases for ROSG

Press Releases
Rosetta Genomics Reports Second Quarter Financial Results, Provides Business Update
Rosetta Genomics and Warnex Medical Laboratories Announce Exclusive Distribution Agreement for Rosetta’s microRNA-based Assays in Canada
Rosetta Genomics Passes California, Rhode Island, and Maryland CLIA Certification; Files 2008 Audited Financial Statements on Form 6-K
Rosetta Genomics To Present At The Eighth Annual Needham and Company Biotechnology and Medical Technology Conference
Rosetta Genomics Reports First Quarter Financial Results, Announces Sale of Parkway Clinical Laboratories
Rosetta Genomics Announces Upcoming Scientific Presentations, Posters, and New Publication
Rosetta Genomics to Hold First Quarter Conference Call on May 21
Rosetta Genomics Announces Closing of License and Collaboration Agreement
Rosetta Genomics to Give Oral Presentation on Colon Cancer Screening Diagnostic at AACR Annual Meeting
Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
Rosetta Genomics Reports Fourth Quarter Financial Results, Outlines 2009 Plan Focused on a Noninvasive Colon Cancer Screening Diagnostic
Study Published by Rosetta Genomics and Collaborators in the Journal of Clinical Oncology Shows MicroRNA-based Diagnostic Identifies Squamous Lung Cancer with 96% Sensitivity
Rosetta Genomics to Hold Fourth Quarter Conference Call on March 26
Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum
Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Rosetta Genomics Announces Commercial Availability of its Second MicroRNA-Based Diagnostic Test - miRview(TM) mets; Will Hold Teleconference Today to Discuss Launch of Products
Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests
Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
/C O R R E C T I O N -- Rosetta Genomics Ltd/ - Dec 2 2008 6:29AM
Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
/C O R R E C T I O N -- Rosetta Genomics Ltd/ - Nov 6 2008 12:19PM
Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference
Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Rosetta Genomics is the Winner of the Medical-Biotech Category in This Year's Wall Street Journal Technology Innovation Awards
Rosetta Genomics to Present at Maxim Group Growth Conference
Rosetta Genomics Announces Transfer of MicroRNA-based Liver Therapeutics Project With Isis Pharmaceuticals, Inc. to Regulus Therapeutics LLC
MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
Rosetta Genomics Reports Second Quarter 2008 Financial Results
Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
/C O R R E C T I O N -- Rosetta Genomics Ltd/ - May 27 2008 1:00AM
Rosetta Genomics Reports First Quarter 2008 Financial Results - May 27 2008 1:00AM
Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) - May 27 2008 12:55AM
Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results - May 27 2008 12:52AM
Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology
Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinical Laboratory Evaluation Program